Atomoxetine use attention-deficit hyperactivity disorder and its treatment effects on brain resting-state functional connectivity.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 23 Sep 2015
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacodynamics
- 23 Sep 2015 New trial record
- 16 Sep 2015 Results published in the International Journal of Neuropsychopharmacology.